SEARCH

SEARCH BY CITATION

References

  • 1
    Arimatsu Y. & Hatanaka H. (1986) Estrogen treatment enhances survival of cultured fetal rat amygdala neurons in a defined medium. Dev. Brain Res. 26 151159.
  • 2
    Bachman D.L., Wolf P.A., Linn R., Knoefel J.E., Cobb J., Belanger A., D'Agostino R.B., White L.R. (1992) Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham study. Neurology 42 115119.
  • 3
    Behl C., Widmann M., Trapp T., Holsboer F. (1995) 17-β Estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216 473482.
  • 4
    Behl C., Skutella T., 'H F., Post A., Widmann M., Newton C.J., Holsboer F. (1997) Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51 535541.
  • 5
    Berry M., Nunez A.M., Chambon P. (1989) Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. USA 86 12181222.
  • 6
    Bettini E., Pollio G., Santagati S., Maggi A. (1992) Estrogen receptor in rat brain: presence in the hippocampal formation. Neuroendocrinology 56 502508.
  • 7
    Bhargava V., Kell D.L., Van De Rijn M., Warnke R.A. (1994) Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am. J. Pathol. 145 535540.
  • 8
    Birge S.J. (1997) The role of estrogen in the treatment of Alzheimer’s disease. Neurology 48 S36S41.
  • 9
    Blaustein J.D. (1993) Estrogen receptor immunoreactivity in rat brain: rapid effects of estradiol injection. Endocrinology 132 12181224.
  • 10
    Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nunez G., Thompson C.B. (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74 597608.
  • 11
    Brenner D.E., Kukull W.A., Stergachis A., Van Belle G., Bowen J.D., McCormick W.C., Teri L., Larson E.B. (1994) Postmenopausal estrogen replacement therapy and the risk of Alzheimer’s disease: a population-based case-control study. Am. J. Epidemiol. 140 262267.
  • 12
    Buckwalter J.G., Sobel E., Dunn M.E., Diz M.M., Henderson V.W. (1993) Gender differences on a brief measure of cognitive functioning in Alzheimer’s disease. Arch. Neurol. 50 757760.
  • 13
    Busciglio J., Yeh J., Yankner B.A. (1993) β-Amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins. J. Neurochem. 61 15651568.
  • 14
    Carson J., Schrader W.T., O'Malley B.W. (1990) Steroid receptor family: structure and functions. Endocr. Rev. 11 201220.
  • 15
    Chinnaiyan A.M., Orth K., O'Rourke K., Duan H., Poirier G.G., Dixit V.M. (1996) Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem. 271 45734576.
  • 16
    Cotman C.W. & Anderson A.J. (1995) A potential role for apoptosis in neurodegeneration and Alzheimer’s disease. Mol. Neurobiol. 10 1945.
  • 17
    Cummings B.J., Pike C.J., Shankle S., Cotman C.W. (1996) β-Amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer’s disease. Neurobiol. Aging 17 921933.
  • 18
    Doglioni C., Dei T.A., Laurino L., Chiarelli C., Barbareschi M., Viale G. (1994) The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Arch. 424 4751.
  • 19
    Doraiswamy P.M., Bieber F., Kaiser L., Krishnan K.R., Reuning S.J., Gulanski B. (1997) The Alzheimer’s Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer’s disease trials. Neurology 48 15111517.
  • 20
    Eppenberger U., Wosikowski K., Kung W. (1991) Pharmacologic and biologic properties of droloxifene, a new antiestrogen. Am. J. Clin. Oncol. 14 (Suppl. 2) , S5S14.
  • 21
    Faivre-Bauman A., Rosenbaum E., Puymirat J., Grouselle D., Tixier-Vidal A. (1981) Differentiation of fetal mouse hypothalamic cells in serum-free medium Dev. Neurosci. 4 118129.
  • 22
    Fillit H., Weinreb H., Cholst I., Luine V., McEwen B., Amador R., Zabriskie J. (1986) Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer’s type. Psychoneuroendocrinology 11 337345.
  • 23
    Forloni G., Chiesa R., Smiroldo S., Verga L., Salmona M., Tagliavini F., Angeretti N. (1993) Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25-35. Neuroreport 4 523526.
  • 24
    Garcia-Segura L.M., Cardon P., Naftolin F., Chowen J.A. (1998) Estradiol upregulates bcl-2 expression in adult brain neurons. Neuroreport 9 593597.
  • 25
    Gompel A., Sabourin J.C., Martin A., Yaneva H., Audouin J., Decroix Y., Poitout P. (1994) Bcl-2 expression in normal endometrium during the menstrual cycle. Am. J. Pathol. 144 11951202.
  • 26
    Gonzalez-Garcia M., Garcia I., Ding L., O'Shea S., Boise L.H., Thompson C.B., Nuñez G. (1995) bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc. Natl. Acad. Sci. USA 92 43044308.
  • 27
    Goodman Y., Bruce A.J., Cheng B., Mattson M.P. (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66 18361844.
  • 28
    Green P.S., Bishop J., Simpkins J.W. (1997) 17-α-Estradiol exerts neuroprotective effects on SK-N-SH cells. J. Neurosci. 17 511515.
  • 29
    Greenberg S.G. & Davies P. (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. USA 87 58275831.
  • 30
    Grillot D.A.M., González-García M., Ekhterae D., Duan L., Inohara N., Ohta S., Seldin M.F., Nuñez G. (1997) Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J. Immunol. 158 47504757.
  • 31
    Henderson V.W. (1997) The epidemiology of estrogen replacement therapy and Alzheimer’s disease. Neurology 48 S27S35.
  • 32
    Henderson V.W. & Buckwalter J.G. (1994) Cognitive deficits of men and women with Alzheimer’s disease. Neurology 44 9096.
  • 33
    Henderson V.W., Paganini H.A., Emanuel C.K., Dunn M.E., Buckwalter J.G. (1994) Estrogen replacement therapy in older women. Comparisons between Alzheimer’s disease cases and nondemented control subjects. Arch. Neurol. 51 896900.
  • 34
    Honjo H., Ogino Y., Naitoh K., Urabe M., Kitawaki J., Yasuda J., Yamamoto T., Ishihara S., Okada H., Yonezawa T., Hayashi K., Nambara T. (1989) In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer’s type). J. Steroid Biochem. 34 521525.
  • 35
    Huang Y., Ray S., Reed J.C., Ibrado A.M., Tang C., Nawabi A., Bhalla K. (1997) Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Res. Treat. 42 7381.
  • 36
    Hyder S.M., Stancel G.M., Nawaz Z., McDonnell D.P., Loose-Mitchell D.S. (1992) Identification of an estrogen response element in the 3′-flanking region of the murine c-fos protooncogene. J. Biol. Chem. 267 1804718054.
  • 37
    Kaiser F.E. & Morley J.E. (1995) Reproductive hormonal changes in the aging male, in Hormones and Aging (Timiras P. S., Quay W. B., and Vernadakis A., eds), pp. 153166. CRC Press, Boca Raton, Florida.
  • 38
    Kandouz M., Siromachkova M., Jacob D., Chretien Marquet B., Therwath A., Gompel A. (1996) Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells. Int. J. Cancer 68 120125.DOI: 10.1002/(SICI)1097-0215(19960927)68:1<120::AID-IJC21>3.0.CO;2-E
  • 39
    Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D.D., Metter E. (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: the Baltimore Longitudinal Study of Aging. Neurology 48 15171521.
  • 40
    Keller J.N., Germeyer A., Begley J.G., Mattson M.P. (1997) 17β-Estradiol attenuates oxidative impairment of synaptic Na+/K+-ATPase activity, glucose transport, and glutamate transport induced by amyloid β-peptide and iron. J. Neurosci. Res. 50 522530.
  • 41
    Klein-Hitpass L., Ryffel G.U., Heitlinger E., Cato A.C. (1988) A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. Nucleic Acids Res. 16 647663.
  • 42
    Koh J., Yang L.L., Cotman C.W. (1990) β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533 315320.
  • 43
    Krajewski S., Krajewska M., Shabaik A., Wang H.G., Irie S., Fong L., Reed J.C. (1994) Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res. 54 55015507.
  • 44
    Kumar V. & Chambon P. (1988) The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55 145156.
  • 45
    Loo D.T., Copani A., Pike C.J., Whittemore E.R., Walencewicz A.J., Cotman C.W. (1993) Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA 90 79517955.
  • 46
    Lorenzo A. & Yankner B.A. (1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. USA 91 1224312247.
  • 47
    Maggi A., Susanna L., Bettini E., Mantero G., Zucchi I. (1989) Hippocampus: a target for estrogen action in mammalian brain. Mol. Endocrinol. 3 11651170.
  • 48
    Mashima T., Naito M., Noguchi K., Miller D.K., Nicholson D.W., Tsuruo T. (1997) Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene 14 10071012.
  • 49
    Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R. (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12 376389.
  • 50
    Mattson M.P., Robinson N., Guo Q. (1997) Estrogens stabilize mitochondrial function and protect neural cells against the proapoptotic action of mutant presenilin-1. Neuroreport 8 38173821.
  • 51
    McEwen B.S., Alves S.E., Bulloch K., Weiland N.G. (1997) Ovarian steroids and the brain: implications for cognition and aging. Neurology 48 (Suppl. 7) , S8S15.
  • 52
    Mizuguchi M., Sohma O., Takashima S., Ikeda K., Yamada M., Shiraiwa N., Ohta S. (1996) Immunochemical and immunohistochemical localization of Bcl-x protein in the rat central nervous system. Brain Res. 712 281286.
  • 53
    Mook-Jung I., Joo I., Sohn S., Kwon H.J., Huh K., Jung M.W. (1997) Estrogen blocks neurotoxic effects of β-amyloid (1-42) and induces neurite extension on B103 cells. Neurosci. Lett. 235 101104.
  • 54
    Mooradian A.D. (1993) Antioxidant properties of steroids. J. Steroid Biochem. Mol. Biol. 45 509511.
  • 55
    Ohkura T., Isse K., Akazawa K., Hamamoto M., Yaoi Y., Hagino N. (1994) Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr. J. 41 361371.
  • 56
    O'Keefe J.A., Li Y., Burgess L.H., Handa R.J. (1995) Estrogen receptor mRNA alterations in the developing rat hippocampus. Mol. Brain Res. 30 115124.
  • 57
    Otsuki Y., Misaki O., Sugimoto O., Ito Y., Tsujimoto Y., Akao Y. (1994) Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle. Lancet 344 2829.
  • 58
    Paganini-Hill A. & Henderson V.W. (1994) Estrogen deficiency and risk of Alzheimer’s disease in women. Am. J. Epidemiol. 140 256261.
  • 59
    Pike C.J. & Cotman C.W. (1993) Cultured GABA-immunoreactive neurons are resistant to toxicity induced by β-amyloid. Neuroscience 56 269274.
  • 60
    Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. (1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13 16761687.
  • 61
    Pike C.J., Cummings B.J., Monzavi R., Cotman C.W. (1994) β-Amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer’s disease. Neuroscience 63 517531.
  • 62
    Pike C.J., Cummings B.J., Cotman D.W. (1995a) Early association of reactive astrocytes with senile plaques in Alzheimer’s disease. Exp. Neurol. 132 172179.
  • 63
    Pike C.J., Walencewicz-Wasserman A.J., Kosmoski J., Cribbs D.H., Glabe C.G., Cotman C.W. (1995b) Structure-activity analyses of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64 253265.
  • 64
    Pike C.J., Vaughan P.J., Cunningham D.D., Cotman C.W. (1996) Thrombin attenuates neuronal cell death and modulates astrocyte reactivity induced by β-amyloid in vitro. J. Neurochem. 66 13741382.
  • 65
    Pike C.J., Ramezan-Arab N., Cotman C.W. (1997) β-Amyloid neurotoxicity in vitro: evidence of oxidative stress by not protection by antioxidants. J. Neurochem. 69 16011611.
  • 66
    Register T.C., Shively C.A., Lewis C.E. (1998) Expression of estrogen receptor α and β transcripts in female monkey hippocampus and hypothalamus. Brain Res. 788 320322.
  • 67
    Schneider L.S., Farlow M.R., Henderson V.W., Pogoda J.M. (1996) Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer’s disease. Neurology 46 15801584.
  • 68
    Shi S., Gu J., Kalra K.L., Chen T., Cote R.J., Taylor C.R. (1995) Antigen retrieval technique: a novel approach to immunohistochemistry on routinely processed tissue sections. Cell Vis. 2 622.
  • 69
    Simerly R.B., Chang C., Muramatsu M., Swanson L.W. (1990) Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 294 7695.
  • 70
    Singer C.A., Rogers K.L., Strickland T.M., Dorsa D.M. (1996) Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci. Lett. 212 1316.
  • 71
    Srinivasan A., Foster L.M., Testa M.P., Ord T., Keane R.W., Bredesen D.E., Kayalar C. (1996) Bcl-2 expression in neural cells blocks activation of ICE/CED-3 family proteases during apoptosis. J. Neurosci. 16 56545660.
  • 72
    Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet 348 429432.
  • 73
    Teixeira C., Reed J.C., Pratt M.A. (1995) Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 55 39023907.
  • 74
    Tohgi H., Utsugisawa K., Yamagata M., Yoshimura M. (1995) Effects of age on messenger RNA expression of glucocorticoid, thyroid hormone, androgen, and estrogen receptors in postmortem human hippocampus. Brain Res. 700 245253.
  • 75
    Tomiyama T., Shoji A., Kataoka K., Suwa Y., Asano S., Kaneko H., Endo N. (1996) Inhibition of amyloid β protein aggregation and neurotoxicity by rifampicin. J. Biol. Chem. 271 68396844.
  • 76
    Villa P., Kaufman S.H., Earnshaw W.C. (1997) Caspases and caspase inhibitors. Trends Biochem. Sci. 22 388393.
  • 77
    Wang T.T.Y. & Phang J.M. (1995) Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res. 55 24872489.
  • 78
    Weaver C.E.J, Park C.M., Gibbs T.T., Farb D.H. (1997) 17β-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res. 761 338341.
  • 79
    Weiland N.G., Orikasa C., Hayashi S., McEwen B.S. (1997) Distribution and hormone regulation of estrogen receptor immunoreactive cells in the hippocampus of male and female rats. J. Comp. Neurol. 388 603612.DOI: 10.1002/(SICI)1096-9861(19971201)388:4<603::AID-CNE8>3.0.CO;2-6
  • 80
    Yachnis A.T., Powell S.Z., Olmsted J.J., Eskin T.A. (1997) Distinct neurodevelopmental patterns of bcl-2 and bcl-x expression are altered in glioneuronal hamartias of the human temporal lobe. J. Neuropathol. Exp. Neurol. 56 186198.
  • 81
    Yang F., Sun X., Beech W., Teter B., Wu S., Sigel J., Vinters H., Frautschy S.A., Cole G.M. (1998) Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque associated neurons and microglia in Alzheimer’s disease. Am. J. Pathol. 152 379389.
  • 82
    Yankner B.A. (1996) Mechanisms of neuronal degeneration in Alzheimer’s disease. Neuron 16 921932.
  • 83
    Zhang M.Y., Katzman R., Salmon D., Jin H., Cai G.J., Wang Z.Y., Qu G.Y., Grant I., Yu E., Levy P. (1990) The prevalence of dementia and Alzheimer’s disease in Shanghai, China: impact of age, gender, and education. Ann. Neurol. 27 428437.
  • 84
    Zhang Z., Rydel R.E., Drzewiecki G.J., Fuson K., Wright S., Wogulis M., Audia J.E., May P.C., Hyslop P.A. (1996) Amyloid β-mediated oxidative and metabolic stress in rat cortical neurons: no direct evidence for a role for H2O2 generation. J. Neurochem. 67 15951606.